Hongchi Jiang
Nanjing University of Chinese Medicine(CN)Harbin Medical University(CN)Sun Yat-sen University(CN)Chinese Academy of Medical Sciences & Peking Union Medical College(CN)Stomatology Hospital(CN)First Affiliated Hospital of Harbin Medical University(CN)Chengdu University of Traditional Chinese Medicine(CN)
Publications by Year
Research Areas
Cancer, Hypoxia, and Metabolism, Pancreatitis Pathology and Treatment, Cancer Mechanisms and Therapy, Pancreatic and Hepatic Oncology Research, Autophagy in Disease and Therapy
Most-Cited Works
- → Hypoxia-mediated sorafenib resistance can be overcome by EF24 through Von Hippel-Lindau tumor suppressor-dependent HIF-1α inhibition in hepatocellular carcinoma(2013)293 cited
- → Inhibition of Akt Reverses the Acquired Resistance to Sorafenib by Switching Protective Autophagy to Autophagic Cell Death in Hepatocellular Carcinoma(2014)283 cited
- → MiR-21 mediates sorafenib resistance of hepatocellular carcinoma cells by inhibiting autophagy via the PTEN/Akt pathway(2015)213 cited
- → LncRNA SNHG1 contributes to sorafenib resistance by activating the Akt pathway and is positively regulated by miR-21 in hepatocellular carcinoma cells(2019)204 cited
- → Laparoscopic Versus Open Nephroureterectomy for the Treatment of Upper Urinary Tract Urothelial Carcinoma: A Systematic Review and Cumulative Analysis of Comparative Studies(2012)194 cited
- → Dihydroartemisinin inactivates NF-κB and potentiates the anti-tumor effect of gemcitabine on pancreatic cancer both in vitro and in vivo